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UMOD promoter is associated with end
stage renal disease
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Abstract
Background: Several genome-wide association studies revealed that several variants of UMOD gene were related
to the estimated glomerular filtration rate (eGFR), CKD or hypertension. In this study, we investigated the association
between a common variant rs13333226 in the promoter region of UMOD gene and end stage renal disease (ESRD).
Methods: Variant rs13333226 of UMOD gene was genotyped by using the ABI Real time TaqMan allelic discrimination
assay in a case-control study including 638 unrelated patients with ESRD and 366 controls.
Results: The frequency of UMOD SNP rs13333226 GG/GA genotype was significantly higher (36.83% vs. 20.22%, P = 4.
02 × 10-8) and the frequency of G allele was much higher (19.04% vs. 11.20%, P = 4.00 × 10−6) in the patients with ESRD
than in the controls. The G allele was associated with an increased risk of ESRD (odds ratio 2.30, 95% confidence interval
1.70–3.11, P = 6.10 × 10−8). And G allele (odds ratio 2.33, 95% confidence interval 1.32–4.13, P = 3.65 × 10−3) was
associated independently with ESRD.
Conclusions: A common variation rs13333226 in the promoter region of UMOD gene was independently associated
with ESRD in Han Chinese.
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Background
End stage renal disease (ESRD), was one of the most ser-
ious principal challenges and resulted in a serious public
health and financial burden worldwide. In addition,
ESRD caused high morbidity and was an independent
risk factor for cardiovascular disease or overall mortality
in patients with chronic kidney disease (CKD) [1, 2]. It
affected over 0.03% of the Chinese adult population [3].
Multiple factors were involved in the progression of
kidney diseases into ESRD, and the development of
ESRD was the result of interaction between genes and
environment [4–7]. Familial clustering phenomenon was
common in patients with ESRD [4, 5, 7, 8]. A recent
study reported that a CKD patients, who had a first-
degree relative with ESRD, significantly increased the
relative risk of developing ESRD [8]. Polymorphisms of
many genes were reported to be associated with ESRD,
such as ACE, APOL1, and MUC1 [7].
Recently, several genome-wide association studies
(GWAS) showed that lots of genetic risk loci (such as:
rs12917707, rs4293393, and rs6497476) were associated
with estimated glomerular filtration rate (eGFR), CKD or
hypertension [9–13]. Most studies consistently showed
that the common variant rs12917707 of the UMOD
gene have been strongly associated with eGFR, preva-
lent and incident CKD and ESRD in general population
cohorts [9, 11, 14]. The relationship between T allele of
rs12917707 and lower risk of CKD and ESRD was con-
firmed in other two case-control studies [15, 16]. These
results suggested that the variants of UMOD gene con-
tributed to the genetic susceptibility to ESRD. But a
study recently reported that the association between
rs12917707 and GFR was not observed in Italian dia-
betic patients [17]. And the minor allele frequency of
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rs12917707 (T allele) was only 1% in Han Chinese (http://
hapmap.ncbi.nlm.nih.gov/index.html.en). Another single
nucleotide polymorphism (SNP) in the promoter region of
UMOD gene, rs13333226, was reported to be associated
with hypertension, and serum uric level [18, 19]. The G
allele carriers had higher diastolic blood pressure and
higher plasma uric acid compared with A/A homozygotes
[18, 19]. In this study, we explored the association be-
tween rs13333226 and the susceptibility to ESRD.
Methods
Patients and clinical data
Total 638 unrelated Han Chinese patients with ESRD
were recruited from southwest of China. The diagnostic
criteria of ESRD were eGFR less than 15 or have re-
ceived dialysis (hemodialysis or peritoneal dialysis). The
patient who had acute kidney injury was excluded. The
average age of their onset of ESRD (CKD 5 or 5D) was
54.1 ± 16.0 years old (from 14 to 87 years old). The pri-
mary causes of ESRD included chronic glomeruloneph-
ritis (CGN), diabetic kidney disease (DKD), hypertensive
nephropathy (HTN), as well as other causes. Three hun-
dred and sixty-six healthy individuals served as controls.
All the controls didn’t have hypertension, diabetes, as
well as acute or chronic kidney diseases. The average
age of the controls was 52.9 ± 13.3 years-old (from 18 to
87 years old). The protocol was approved by the Ethics
Review Committee of Sichuan Provincial People’s Hos-
pital. Informed consent was signed by all subjects.
DNA extraction and genotyping
DNA was extracted from peripheral blood collected
from patients with ESRD and healthy controls by using
‘salting-out’ method. The genotyping was conducted by
real–time PCR. The primers and probe were obtained
from Applied Biosystems (ABI, Foster city, CA). Geno-
typing of the rs13333226 SNP in the UMOD gene was
performed using an ABI 7900 Real-time System (ABI,
Foster city, CA). Assays were run at a final volume of
25 μl consisting of 12.5 μl of TaqMan®Gene Expression
Master mix (ABI, Foster city, CA), 7.5 μl of primers (400
nM both forward and reverse) and probe (200 nM) (final
concentration), 5 μl of input target DNA. Genotype clus-
tering and calling were performed using SDS 2.3 Soft-
ware (ABI, Foster city, CA).
Statistical analyses
Deviation from Hardy-Weinberg equilibrium was tested
in healthy controls. Comparison of genotype and allele
frequency between patient group and control group was
done by X2 test. Genotype-phenotype associations were
tested under dominant as well as recessive genetic
model. The effect of genotype on ESRD was also investi-
gated with logistic regression analysis. Statistical analyses
were performed using SPSS 17.0 software package (SPSS
Inc., Chicago, IL). Statistical power was calculated by a
software “PS: Power and Sample Size Calculation” [20].
The SNP data of UMOD gene derived from 1000 Ge-
nomes project (GRCh38) CHB (Chinese Han Beijing) +
CHS (Chinese Han South) were used to perform pair-
wise linkage disequilibrium analysis between rs13333226
and the previous GWAS hit rs12917707, rs4293393, as
well as rs6497476 by Haploview software [21].
Results
The percentage of male in the cases was much higher
than in the controls (55.8% vs. 33.9%, P = 2.20 × 10−11).
The demographic and clinical data were listed in Table 1.
There was no deviation from Hardy-Weinberg equilib-
rium in controls (P = 0.073). The coefficient (r2) for pair-
wise linkage disequilibrium (LD) between rs13333226
and rs12917707, rs4293393, as well as rs6497476 were
0.099, 1, 0.883, respectively.
Compared to the healthy controls, the frequency of
UMOD SNP rs13333226 GG/GA genotype was signifi-
cantly higher (36.83% vs. 20.22%, P = 4.02 × 10-8) and the
frequency of G allele was much higher in the patients with
ESRD (19.04% vs. 11.20%, P = 4.00 × 10−6). The frequen-
cies of GG/GA genotype and G allele were also much
higher in ESRD patients with diabetes mellitus, without
diabetes mellitus, or with hypertension (Table 2). For male
individuals, the frequency of GG/GA genotype was much
higher in patients than in controls (35.4% vs. 21.8%,
P = 5.10 × 10−3), and for female individuals, the differ-
ence was significant (38.4% vs. 19.7%, P = 2.00 × 10−6).
The G allele was associated with higher risk of ESRD in
dominant model [odds ratio (OR) = 2.30, 95% confidence
interval (CI): 1.70–3.11, P = 6.10 × 10−8] with a statistical
power of 1.00, in an additive model (OR = 1.96, 95%CI:
1.48–2.60,P = 2.00 × 10−6), but not in recessive model
(OR = 0.57, 95% CI: 0.21–1.53, P = 0.26). The G allele
was significantly associated with ESRD in dominant
model in the subgroup of patients without diabetes
mellitus (N = 538, OR = 2.21, 95% CI: 1.62–3.01, P =







Male, n (%) 356 (55.8%) 124 (33.9%) 2.20 × 10−11
Age (y) 54.1 ± 16.0 52.9 ± 13.3 0.13
Primary causes of ESRD
Chronic glomerulonephritis 250 (39.2%) - -
Diabetic kidney disease 100 (15.7%) - -
Hypertensive nephropathy 87 (13.6%) - -
Other causes 95 (14.9%) - -
Unknown 106 (16.6%) - -
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5.55 × 10−7), with diabetes mellitus (N = 100, OR = 2.86,
95% CI: 1.78–4.58, P = 1.30 × 10−5), as well as with
hypertension (N = 569, OR = 2.29, 95% CI: 1.69–3.11,
P = 1.19 × 10−7).
The effect of genotype on ESRD was also investigated
by a multivariable logistic regression analysis including
age of initial ESRD, sex, hypertension and diabetic melli-
tus. The result showed that male (OR = 2.05, 95% CI:
1.19–3.51, P = 9.31 × 10−3) and G allele at rs13333226
(OR = 2.33, 95% CI: 1.32–4.13, P = 3.65 × 10−3) was inde-
pendently associated with the susceptibility to ESRD.
Discussion
UMOD gene encodes Tamm-Horsfall protein, also known
as uromodulin, which is a glycoprotein exclusively synthe-
sized by the thick ascending limb (TAL) and early distal
convoluted tubule in the kidney [22]. Lots of studies re-
vealed that the variants of UMOD were associated with
different risk of CKD, cardiovascular disease, hyperten-
sion, and hyperuricemia, T allele of rs12917707 was as-
sociated with lower risk of CKD and ESRD [9, 10, 18,
19, 23, 24]. But the relationship between variants of
UMOD and risk of kidney disease was complicated, the
several rare mutation in UMOD gene has been de-
scribed as a cause of uromodulin-associated kidney dis-
ease, an autosomal dominant disease [25, 26]. Prudente
et al. recently demonstrated that the previously re-
ported strong association between rs12917707 and GFR
in diabetic patients from Sweden was not observed in
Italian diabetic patients [17]. It suggested that there
was a heterogeneous effect across the two different
samples [17]. In this study, we investigated the associ-
ation between a promoter SNP rs13333226 of UMOD
and susceptibility to ESRD.
Our results indicated that the frequency of rs13333226
GG/GA genotype and G allele was significantly higher in
the patients with ESRD, compared to healthy controls.
The G allele was associated with higher risk of ESRD in
dominant model. G allele and male was associated inde-
pendently with the susceptibility to ESRD by multivari-
ate logistic analysis. This relationship still existed after
adjusted by sex, age, as well as presence or absence of
diabetes mellitus and hypertension. Our results demon-
strated that rs13333226 didn’t correlate tightly with
rs12917707 in Chinese Han population. It suggested that
the effect of rs13333226 on CKD or ESRD was different
from rs12917707. A previous case-control association
study showed that G allele of rs13333226 was independ-
ently associated with a decreased risk of nephropathy,
and the G allele was also associated with a higher eGFR
and lower systolic blood pressure in the study cohort
[27]. However, two other studies have shown that G al-
lele carriers have higher diastolic blood pressure and
higher plasma uric acid compared with A/A homozy-
gotes [18, 19].
The G allele at rs13333226 and C allele at rs6497476
were demonstrated to increase transcriptional activity in
HEK-293 cells and mlMCD3 cells by luciferase reporter
assay [19]. The rs13333226 G allele carriers have higher
plasma uric acid than A/A homozygotes [19]. Higher
serum uric acid was reported to associate significantly
with increased risk for kidney functional impairment
and SUA ≥6.0 mg/dL was a significant risk factor for
rapid decline in eGFR [28]. In a prospective children
and adolescents cohort study, those with higher uric acid
levels (≥5.5 mg/dL) had shorter times to renal outcomes
by a multivariable parametric time-to-event analysis
[29]. Trudu et al. reported that two UMOD risk variants
(G allele of rs12917707 and T allele of rs4293393) in-
creased UMOD expression which led to salt-sensitive
hypertension and to the presence of age-dependent renal
lesions in transgenic mice [24]. High expression of uro-
modulin could activate the renal sodium cotransporter
NKCC2 which induced hypertension in UMOD trans-
genic mouse model [24]. UMOD has also proved to regu-
late the renal outer medullary potassium channel, thus
Table 2 The frequencies of genotypes and alleles of rs1333326 in cases and controls groups
Genotype frequency Allelic frequency
GG AG AA G A
Control 8 66 292 82 650
All cases 8 227 403 243 1033
X2 = 35.08, P =2.41 × 10−8 X2 = 21.09, P =4.00 × 10−6
Cases with DM a 2 40 58 44 156
X2 = 19.79, P =5.00 × 10−5 X2 = 15.67, P =7.60 × 10−5
Cases without DM a 6 187 345 199 877
X2 = 30.96, P =1.89 × 10−7 X2 = 17.65, P =2.70 × 10−5
Cases with hypertension a 7 202 360 216 922
X2 = 33.69, P =4.84 × 10−8 X2 = 20.12, P =7.00 × 10−6
aCompared to controls
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increasing salt reabsorption along the TAL [30]. It could
be speculated that the G allele at rs13333226 could in-
crease carriers’ risk of ESRD by enhancing UMOD gene
expression, increasing TAL salt reabsorption and serum
uric acid levels, as well as increasing risk of hypertension.
We haven’t detected serum sodium or uric acid levels in
these patients, because the two parameters were influ-
enced by many factors in patients with hemodialysis.
Although there was an independent association be-
tween G allele at rs13333226 and ESRD, we still need
direct functional evidence to illustrate that whether the
G allele at rs13333226 was a causal variant. And a pro-
spective cohort study with large sample size would pro-
vide more solid evidence.
Conclusions
In summary, our data indicates that common genetic
variation rs13333226 in the promoter region of UMOD
gene was independently associated with ESRD in Han
Chinese.
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